BFF MDI (PT009): Clinical Trials

1 trial of BFF MDI (PT009), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow BFF MDI (PT009): new trials by email Literature Review of BFF MDI (PT009) trials Research Report on BFF MDI (PT009)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess the Safety and Efficacy of PT010, PT003, and PT009 in Japanese Subjects With COPD Compared With Symbicort® Turbohaler®
BGF MDI (PT010), GFF MDI (PT003), BFF MDI (PT009) - COPD
Phase 3CompletedPearl Therapeutics, Inc.4162016-08-092020-05-13

Conditions studied

Pulmonary Disease, Chronic Obstructive (1)

Sponsors

Pearl Therapeutics, Inc. (1)

Countries

Japan (1)

Top investigators

Paul M. Dorinsky, MD (1)

Results publications

PMID 35815359